The "Osteopetroses" are genetic diseases whose clinical picture is caused by a defect in bone resorption by osteoclasts. Three main forms can be distinguished on the basis of severity, age of onset and means of inheritance: the dominant benign, the intermediate and the recessive severe form. While several genes have been involved in the pathogenesis of the different types of osteopetroses, the CLCN7 gene has drawn the attention of many researchers, as mutations within this gene are associated with very different phenotypes. We report here the characterization of 25 unpublished patients which has resulted in the identification of 20 novel mutations, including 11 missense mutations, 6 causing premature termination, 1 small deletion and 2 putative splice site defects. Careful analysis of clinical and molecular data led us to several conclusions. First, intermediate osteopetrosis is not homogeneous, since it can comprise both severe dominant forms with an early onset and recessive ones without central nervous system involvement. Second, the appropriateness of haematopoietic stem cell transplantation in CLCN7-dependent ARO patients has to be carefully evaluated and exhaustive CNS examination is strongly suggested, as transplantation can almost completely cure the disease in situations where no primary neurological symptoms are present. Finally, the analysis of this largest cohort of CLCN7-dependent ARO patients together with some ADO II families allowed us to draw preliminary genotype-phenotype correlations suggesting that haploinsufficiency is not the mechanism causing ADO II. The availability of biochemical assays to characterize ClC-7 function will help to confirm this hypothesis. ©2009 Wiley-Liss, Inc.

Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: Report of 20 novel mutations / Pangrazio, A.; Pusch, M.; Caldana, E.; Frattini, A.; Lanino, E.; Tamhankar, P. M.; Phadke, S.; Lopez, A. G. M.; Orchard, P.; Mihci, E.; Abinun, M.; Wright, M.; Vettenranta, K.; Bariae, I.; Melis, D.; Tezcan, I.; Baumann, C.; Locatelli, F.; Zecca, M.; Horwitz, E.; Mansour, L. S. B.; Van Roij, M.; Vezzoni, P.; Villa, A.; Sobacchi, C.. - In: HUMAN MUTATION. - ISSN 1059-7794. - 31:1(2010), pp. E1071-E1080. [10.1002/humu.21167]

Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: Report of 20 novel mutations

Locatelli F.;
2010

Abstract

The "Osteopetroses" are genetic diseases whose clinical picture is caused by a defect in bone resorption by osteoclasts. Three main forms can be distinguished on the basis of severity, age of onset and means of inheritance: the dominant benign, the intermediate and the recessive severe form. While several genes have been involved in the pathogenesis of the different types of osteopetroses, the CLCN7 gene has drawn the attention of many researchers, as mutations within this gene are associated with very different phenotypes. We report here the characterization of 25 unpublished patients which has resulted in the identification of 20 novel mutations, including 11 missense mutations, 6 causing premature termination, 1 small deletion and 2 putative splice site defects. Careful analysis of clinical and molecular data led us to several conclusions. First, intermediate osteopetrosis is not homogeneous, since it can comprise both severe dominant forms with an early onset and recessive ones without central nervous system involvement. Second, the appropriateness of haematopoietic stem cell transplantation in CLCN7-dependent ARO patients has to be carefully evaluated and exhaustive CNS examination is strongly suggested, as transplantation can almost completely cure the disease in situations where no primary neurological symptoms are present. Finally, the analysis of this largest cohort of CLCN7-dependent ARO patients together with some ADO II families allowed us to draw preliminary genotype-phenotype correlations suggesting that haploinsufficiency is not the mechanism causing ADO II. The availability of biochemical assays to characterize ClC-7 function will help to confirm this hypothesis. ©2009 Wiley-Liss, Inc.
2010
Chloride; CNS defects; Osteopetrosis; Transplantation
01 Pubblicazione su rivista::01a Articolo in rivista
Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: Report of 20 novel mutations / Pangrazio, A.; Pusch, M.; Caldana, E.; Frattini, A.; Lanino, E.; Tamhankar, P. M.; Phadke, S.; Lopez, A. G. M.; Orchard, P.; Mihci, E.; Abinun, M.; Wright, M.; Vettenranta, K.; Bariae, I.; Melis, D.; Tezcan, I.; Baumann, C.; Locatelli, F.; Zecca, M.; Horwitz, E.; Mansour, L. S. B.; Van Roij, M.; Vezzoni, P.; Villa, A.; Sobacchi, C.. - In: HUMAN MUTATION. - ISSN 1059-7794. - 31:1(2010), pp. E1071-E1080. [10.1002/humu.21167]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1479869
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 74
  • ???jsp.display-item.citation.isi??? 64
social impact